11 results about "Controlled substance" patented technology

A device includes a reservoir and a therapeutic substance located in the reservoir, where the device is an implantable therapeutic substance delivery device, and the device is configured to deliver the therapeutic substance to a recipient thereof by diffusion controlled release. In an exemplary embodiment, the device is also a cochlear implant.

A system and method are provided for remotely supervised preparation, verification, and controlled dispensing of medication doses at geographically distributed remote dispensing units. A recipient and a supervisor are authenticated. A real-time audiovisual session is established between the recipient and at least the supervisor, and additional authenticated participants may join without authority to actuate dose release. The system receives an electronic medication order and corresponding label data originating from an external clinical information system and authorizes preparation of doses at the remote dispensing unit based on the order. Prior to any release, verification data is presented to the supervisor. A controlled mechanical transfer mechanism is actuated to release a prepared dose to the recipient only after verification and affirmative authorization by an authenticated supervisor. The disclosed systems and methods are applicable to controlled substances and other medications requiring supervised dispensing.

A method, apparatus and computer program product are provided for a compiled standardized measure representative of a subset of prescription transactions associated with a controlled substance. The compiled standardized measures may be used in the prescription domain to notify prescribers of a patient's morphine milligram equivalent (MME) to reduce risks related to drug overdose, abuse, and the like. Historical prescription transactions may be accessed to identify prescriptions classified as an opioid or other controlled substance, and that may likely still be in a patient's possession based upon days supply, such that a daily MME may be calculated. Messaging is provided to the prescriber if the amount exceeds a maximum threshold, and the prescription can be changed accordingly.

A fulfillment system includes a platform for facilitating fulfillment of a prescription for a regulated product, such as a prescription drug, which also has a REMS, along with any applicable controlled substance scheduling requirements. The platform communicates with a computer network of a healthcare provider's office where a healthcare provider or other authorized prescriber issues a prescription for a patient. The platform also communicates with a pharmacy, such as a specialty pharmacy, for fulfillment of the prescription. The system electronically populates documents satisfying documentation requirements pertaining to a REMS, controlled substances regulations, prescriptions, other pertinent patient information, and / or other regulations or rules thereby eliminating paper and redundant documents and reducing the burden on the healthcare provider / healthcare system.

Embodiments of the present disclosure include a network-enabled lockbox for securely dispensing a substance includes a wireless communication device, one or more sensors, and a rotating carousel containing one or more doses of the controlled substance. The carousel provides a dose of the substance during a preconfigured period of time. The one or more sensors detect one or more alert conditions. The wireless communications wirelessly communicate information between the network-enabled lockbox and a remote server. For example, the network-enabled lockbox for securely dispensing a substance includes an outer compartment, an interior frame inserted into the compartment and secured to the compartment, a top plate, a worm drive, an electric motor connected to the worm drive, control electronics for controlling the motor, a carousel connected to the worm drive, a plurality of sensors, and a communications subsystem for communicating data to a backend server.

The invention discloses a detection system and method for preventing ambulance of hemp essence medicine. The detection system comprises a terahertz detection module, an intelligent analysis module and a block chain evidence storage early warning module. The terahertz detection module performs non-contact spectral data acquisition at key nodes of the whole process of raw material storage, production line feeding, intermediate transfer, finished product storage and waste destruction; the intelligent analysis module performs preprocessing and feature extraction on the spectral data, and realizes substance identification and real-time quality monitoring based on a deep learning algorithm; and the block chain evidence storage early warning module carries out tampering-free on-chain evidence storage on the identification result and the related information, and triggers graded early warning and linkage disposal with production equipment when the identification is abnormal or the data deviation exceeds a threshold value. According to the invention, real-time, lossless and credible monitoring and tracing of the whole production process of the hemp extract medicine are realized, and the anti-fraud management and control capability is effectively improved.

This invention belongs to the field of empty bottle recycling technology for controlled substances, specifically relating to an anti-counterfeiting identification system for the recycling of empty bottles of controlled substances. This invention constructs random fingerprint data by extracting microstructural features such as microbubbles, microtextures, and microparticles from the bottle body, giving each empty bottle a unique physical identifier. This effectively avoids the problem of traditional identification codes being easily tampered with or copied. By integrating bottle cap damage features and sealing structure deformation features, it objectively characterizes whether the bottle has actually been opened, avoiding misjudgments caused by relying solely on appearance or markings. By extracting the distribution and diffusion morphology of residual particles on the inner wall and combining it with spatial path modeling, it can reconstruct the flow trajectory and deposition path of the drug within the bottle, thereby improving the ability to identify the actual use of the drug.

The invention discloses an industry priority control new pollutant list identification method, which belongs to the technical field of priority pollutant identification, and comprises the following steps: (1) investigating industry production information, and constructing an industry information database; (2) performing non-targeted screening on the compounds, and constructing a compound database; (3) screening of characteristic pollutants: systematic screening and grouping of industrial characteristic pollutants are carried out on the compounds detected in the step (2) according to industrial practical application, supervised and controlled substances are directly designated as preferential pollutants, uncontrolled compounds are classified according to compound structures, and then subsequent classification is carried out; and (4) risk assessment and classification: according to a subsequent classification result in the step (3), assigning priority pollutants, dividing the priority pollutants into three classes, and performing risk management according to the classes to which the pollutants belong. According to the method, the problems of insufficient industry characteristics and low risk management and control practical operability existing in current industry priority management and control new pollutant identification are solved.

An apparatus and method for administering a substance to an animal or test subject. may include a device having a housing. The housing may include adjustable supports for adapting the device to many different test subject cages or enclosures. The housing may further have a nose-poke region containing a sensor and a substance delivery port. The sensor may determine when an animal or test subject is present within the nose-poke region. When a test subject is present within the nose-poke region, the device may signal for a chamber containing a ceramic disk to vaporize a substance within the chamber. The ceramic disk may vibrate at an ultrasonic frequency to vaporize the substance, which is then delivered to the nose-poke region via tubes connected to the substance delivery port. Excess substance vapor is removed using a constant-negative pressure vacuum attached to the device via a vacuum port.

This invention discloses a method, device, equipment, and medium for dynamic management of controlled substances. The method includes: determining the drug information, dispensing information, and patient identification information corresponding to the controlled substances to be dispensed; allowing the dispensing of the controlled substances after verification based on the drug information, dispensing information, and patient identification information; determining the drug usage information, drug retrieval information, and drug traceability information of the controlled substances to be dispensed; verifying the consistency of use of the controlled substances to be dispensed based on the drug information, dispensing information, patient identification information, drug usage information, drug retrieval information, and drug traceability information; and determining the management log of the controlled substances to be dispensed based on the drug information, dispensing information, patient identification information, dispensing compliance verification results, and usage consistency verification results. This achieves full traceability of drugs from dispensing to use and retrieval, meeting the stringent requirements of controlled substance management regulations.